Recent Publications Affirm the Value of Gene Expression Profile Testing in Guiding a Definitive Diagnosis and Clinical Decision-Making in Melanocytic Lesions of Uncertain Malignant Potenti...
Castle Biosciences, Inc. - Common stock (CSTL)
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm
Check Earnings Report
Company Research
Source: Business Wire
Two studies published in the Journal of Cutaneous Pathology and Melanoma Management demonstrate the significant disagreement that exists in the diagnosis of melanocytic lesions using pathology alone, the variability of surgical management of lesions among treating dermatologists, and the risk-aligned changes and confidence in these decisions that can result from GEP testing1,2 FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of two recent studies that provide further support for the clinical need of its MyPath® Melanoma gene expression profile (GEP) test, designed to aid in providing an accurate diagnosis for ambiguous melanocytic lesions of uncertain malignant potential.“For many concerning pigmented lesions, a definitive histopathologic diagnosis is clear: a malignant melanoma or a benign nevus,” said Matthew Goldberg, M.D., board-certified der
Show less
Read more
Impact Snapshot
Event Time:
CSTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSTL alerts
High impacting Castle Biosciences, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
CSTL
News
- Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare ConferenceBusiness Wire
- Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive YearBusiness Wire
- Castle Biosciences' (NASDAQ:CSTL) Performance Is Even Better Than Its Earnings Suggest [Yahoo! Finance]Yahoo! Finance
CSTL
Earnings
- 11/4/24 - Beat
CSTL
Sec Filings
- 11/19/24 - Form 4
- 11/14/24 - Form 4
- 11/14/24 - Form SC
- CSTL's page on the SEC website